Exploring the Promise of Big Data in Understanding Alzheimer’s Disease

Sage Bionetworks, Inc.
Sage Bionetworks, Inc. (Seattle, Washington)
Year Awarded:
Grant Duration:
January 1, 2014 to March 31, 2015
Alzheimer's Disease
Award Amount:
Grant Reference ID:
Award Type:
Award Region:
US Northwestern

Support for SAGE Bionetworks Alzheimer’s Big Data Dream Challenge #1


The goal of the Alzheimer's Disease Big Data DREAM Challenge #1 (AD#1) is to apply an open science approach to rapidly identify accurate predictive AD biomarkers that can be used by the scientific, industrial and regulatory communities to improve AD diagnosis and treatment. AD#1 is the first in a series of AD Data Challenges to leverage genetics and brain imaging in combination with cognitive assessments, biomarkers and demographic information from cohorts ranging from cognitively normal to mild cognitively impaired to individuals with AD.  This project was funded in collaboration with several industry and non-profit sponsors.

External Links

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.